α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes
Fabry disease (FD) is caused by mutations in the α-galactosidase A (<i>GLA</i>) gene encoding the lysosomal AGAL enzyme. Loss of enzymatic AGAL activity and cellular accumulation of sphingolipids (mainly globotriaosylcermide) may lead to podocyturia and renal loss of function with increa...
Guardado en:
Autores principales: | Ulrich Jehn, Samet Bayraktar, Solvey Pollmann, Veerle Van Marck, Thomas Weide, Hermann Pavenstädt, Eva Brand, Malte Lenders |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/70bbf552057440518a268a3f9bfccd02 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation
por: Solvey Pollmann, et al.
Publicado: (2021) -
In vivo expression of ß-galactosidase by rat oviduct exposed to naked DNA or messenger RNA
por: RIOS,MARIANA, et al.
Publicado: (2002) -
COMPROMISO CARDÍACO EN PACIENTES CON ENFERMEDAD DE FABRY
por: Gómez,María Griselda, et al.
Publicado: (2013) -
Culture conditions for the production of a-galactosidase by Aspergillus parasiticus MTCC-2796: a novel source
por: Shivam,Kumar, et al.
Publicado: (2009) -
Measuring b-Galactosidase activity at pH 6 with a differential pH sensor
por: Acevedo,Cristian, et al.
Publicado: (2009)